Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD
Hanfei Chen, Qiang Chen
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4756-4767
Open Access | Times Cited: 11

Showing 11 citing articles:

Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?
Christoph G. Dietrich, Andreas Geier, Uta Merle
World Journal of Gastroenterology (2023) Vol. 29, Iss. 2, pp. 367-377
Open Access | Times Cited: 14
Global Trends and Inequalities of Liver Complications Related to Metabolic Dysfunction‐Associated Steatotic Liver Disease: An Analysis From 1990 to 2021
Fang Lü, Jinli Liu, Bingyang She, et al.
Liver International (2024)
Open Access | Times Cited: 4
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease
Mohammad Sadiq Jeeyavudeen, Rahul Chaudhari, Joseph M Pappachan, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 3, pp. 487-502
Open Access | Times Cited: 6
The Impact of COVID-19 Pandemic Lockdown on the Relationship between Pediatric MAFLD and Renal Function
Maria Sole Valentino, Pierluigi Marzuillo, Claudia Esposito, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2037-2037
Open Access | Times Cited: 6
Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19
Leonidas Brilakis, Eirini Theofilogiannakou, Panagis M. Lykoudis
World Journal of Gastroenterology (2024) Vol. 30, Iss. 11, pp. 1480-1487
Open Access | Times Cited: 1
Location Decision of Emergency Medical Supply Distribution Centers Under Uncertain Environment
Liu Yong, Meiru Wang, Yong Wang
International Journal of Fuzzy Systems (2024) Vol. 26, Iss. 5, pp. 1567-1603
Closed Access | Times Cited: 1
Health in All Policies: Working Across Sectors in Cooperative Extension to Promote Health for All
Michele Walsh, Deborah H. John, Nicole Peritore, et al.
Journal of Human Sciences and Extension (2018)
Open Access | Times Cited: 7
Metabolic abnormalities in patients with non-alcoholic fatty liver disease with immune response to SARS-CoV-2
Yu.М. Stepanov, В.І. Діденко, І.А. Кленіна, et al.
GASTROENTEROLOGY (2024) Vol. 58, Iss. 1, pp. 25-30
Open Access
Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review
Abdul Moeed, Muhammad Omar Larik, Muhammad Ahmed Ali Fahim, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 8, pp. 1185-1198
Open Access
Implications of metabolic dysfunction associated fatty liver disease in COVID-19
Raja Chakraborty, Deepak Sharma, Devesh U. Kapoor, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 6, pp. 1275-1286
Open Access | Times Cited: 1
The global battle against SARS-CoV-2 and COVID-19 at the third year
Chu‐Xia Deng
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4792-4794
Open Access | Times Cited: 1
Page 1

Scroll to top